0001213900-19-009006.txt : 20190516 0001213900-19-009006.hdr.sgml : 20190516 20190516161256 ACCESSION NUMBER: 0001213900-19-009006 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190516 DATE AS OF CHANGE: 20190516 EFFECTIVENESS DATE: 20190516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RELMADA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001553643 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455401931 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-339798 FILM NUMBER: 19832373 BUSINESS ADDRESS: STREET 1: 750 THIRD AVENUE, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-547-9591 MAIL ADDRESS: STREET 1: 750 THIRD AVENUE, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: CAMP NINE, INC. DATE OF NAME CHANGE: 20120706 D 1 primary_doc.xml X0708 D LIVE 0001553643 RELMADA THERAPEUTICS, INC. 880 THIRD AVENUE, 12TH FLOOR NEW YORK NY NEW YORK 10022 212-547-9591 NEVADA Camp Nine, Inc. CAMP NINE, INC. Corporation true Sergio Traversa 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Executive Officer Director CEO Charles Casamento 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Director Chairman of the Board Paul Kelly 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Director Maged Shenouda 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Director Ottavio Vitolo 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Executive Officer Chief Medical Officer Biotechnology No Revenues 06b false 2019-05-14 false true true false 10000 Alexander Capital, LP 40077 None None 17 STATE STREET 5TH FLOOR NEW YORK NY NEW YORK 10004 AZ ARIZONA CA CALIFORNIA FL FLORIDA GA GEORGIA MD MARYLAND NV NEVADA NJ NEW JERSEY NY NEW YORK SC SOUTH CAROLINA WY WYOMING false Brookline Capital Markets, A division of CIM Securities, LLC 120852 None None 509 MADISON AVENUE, SUITE 906 NEW YORK NY NEW YORK 10022 AL ALABAMA CA CALIFORNIA FL FLORIDA MD MARYLAND NV NEVADA NJ NEW JERSEY NY NEW YORK OH OHIO SC SOUTH CAROLINA TX TEXAS WY WYOMING false 10000000 3414505 6585495 false 43 221150 0 Alexander Capital and Brookline received a cash fee (excluding expenses) of $72,650 and $148,500, respectively, and warrants to purchase an aggregate of 147,433 shares of common stock. 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false RELMADA THERAPEUTICS, INC. /s/ Sergio Traversa Sergio Traversa CEO 2019-05-16